Literature DB >> 14727786

Measuring the quality of diabetes care using administrative data: is there bias?

Nancy L Keating1, Mary Beth Landrum, Bruce E Landon, John Z Ayanian, Catherine Borbas, Edward Guadagnoli.   

Abstract

OBJECTIVES: Health care organizations often measure processes of care using only administrative data. We assessed whether measuring processes of diabetes care using administrative data without medical record data is likely to underdetect compliance with accepted standards for certain groups of patients. DATA SOURCES/STUDY
SETTING: Assessment of quality indicators during 1998 using administrative and medical records data for a cohort of 1,335 diabetic patients enrolled in three Minnesota health plans. STUDY
DESIGN: Cross-sectional retrospective study assessing hemoglobin A1c testing, LDL cholesterol testing, and retinopathy screening from the two data sources. Analyses examined whether patient or clinic characteristics were associated with underdetection of quality indicators when administrative data were not supplemented with medical record data. DATA COLLECTION/EXTRACTION
METHODS: The health plans provided administrative data, and trained abstractors collected medical records data. PRINCIPAL
FINDINGS: Quality indicators that would be identified if administrative data were supplemented with medical records data are often not identified using administrative data alone. In adjusted analyses, older patients were more likely to have hemoglobin A1c testing underdetected in administrative data (compared to patients <45 years, OR 2.95, 95 percent CI 1.09 to 7.96 for patients 65 to 74 years, and OR 4.20, 95 percent CI 1.81 to 9.77 for patients 75 years and older). Black patients were more likely than white patients to have retinopathy screening underdetected using administrative data (2.57, 95 percent CI 1.16 to 5.70). Patients in different health plans also differed in the likelihood of having quality indicators underdetected.
CONCLUSIONS: Diabetes quality indicators may be underdetected more frequently for elderly and black patients and the physicians, clinics, and plans who care for such patients when quality measurement is based on administrative data alone. This suggests that providers who care for such patients may be disproportionately affected by public release of such data or by its use in determining the magnitude of financial incentives.

Entities:  

Mesh:

Year:  2003        PMID: 14727786      PMCID: PMC1360962          DOI: 10.1111/j.1475-6773.2003.00191.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  27 in total

1.  Racial differences in the treatment of early-stage lung cancer.

Authors:  P B Bach; L D Cramer; J L Warren; C B Begg
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  American Diabetes Association: clinical practice recommendations 2002.

Authors: 
Journal:  Diabetes Care       Date:  2002-01       Impact factor: 19.112

Review 3.  Racial and ethnic disparities in the receipt of cancer treatment.

Authors:  Vickie L Shavers; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2002-03-06       Impact factor: 13.506

4.  The National Committee for Quality Assurance.

Authors:  J K Iglehart
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

5.  Performance reports on quality--prototypes, problems, and prospects.

Authors:  A Epstein
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

6.  Evolution of a quality-based compensation model: the third generation.

Authors:  N Schlackman
Journal:  Am J Med Qual       Date:  1993       Impact factor: 1.852

7.  The validity of self-reported diabetes quality of care measures.

Authors:  J B Fowles; K Rosheim; E J Fowler; C Craft; L Arrichiello
Journal:  Int J Qual Health Care       Date:  1999-10       Impact factor: 2.038

8.  Race, socioeconomic status, and breast cancer treatment and survival.

Authors:  Cathy J Bradley; Charles W Given; Caralee Roberts
Journal:  J Natl Cancer Inst       Date:  2002-04-03       Impact factor: 13.506

9.  Racial differences in the use of revascularization procedures after coronary angiography.

Authors:  J Z Ayanian; I S Udvarhelyi; C A Gatsonis; C L Pashos; A M Epstein
Journal:  JAMA       Date:  1993-05-26       Impact factor: 56.272

10.  The influence of race on the use of surgical procedures for treatment of peripheral vascular disease of the lower extremities.

Authors:  E Guadagnoli; J Z Ayanian; G Gibbons; B J McNeil; F W LoGerfo
Journal:  Arch Surg       Date:  1995-04
View more
  19 in total

1.  Measuring quality in modern managed care.

Authors:  Harold S Luft; R Adams Dudley
Journal:  Health Serv Res       Date:  2003-12       Impact factor: 3.402

2.  Pitfalls of using administrative data for research.

Authors:  David Lieberman
Journal:  Dig Dis Sci       Date:  2010-06       Impact factor: 3.199

3.  Does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer?

Authors:  Nancy L Keating; A James O'Malley; Stephen J Freedland; Matthew R Smith
Journal:  Eur Urol       Date:  2012-04-19       Impact factor: 20.096

4.  Using performance data to identify preferred hospitals.

Authors:  Meredith B Rosenthal; Mary Beth Landrum; Ellen Meara; Haiden A Huskamp; Rena M Conti; Nancy L Keating
Journal:  Health Serv Res       Date:  2007-12       Impact factor: 3.402

5.  A clinically guided approach for improving performance measurement for hypertension.

Authors:  Michael A Steinman; Sei J Lee; Carolyn A Peterson; Kathy Z Fung; Mary K Goldstein
Journal:  Med Care       Date:  2012-05       Impact factor: 2.983

6.  Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.

Authors:  Nancy L Keating; A James O'Malley; Stephen J Freedland; Matthew R Smith
Journal:  J Natl Cancer Inst       Date:  2009-12-07       Impact factor: 13.506

7.  Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer.

Authors:  Nancy L Keating; Pang-Hsiang Liu; A James O'Malley; Stephen J Freedland; Matthew R Smith
Journal:  Eur Urol       Date:  2013-02-22       Impact factor: 20.096

8.  Combining information from cancer registry and medical records data to improve analyses of adjuvant cancer therapies.

Authors:  Yulei He; Alan M Zaslavsky
Journal:  Biometrics       Date:  2009-02-04       Impact factor: 2.571

9.  Methods to identify the target population: implications for prescribing quality indicators.

Authors:  Liana Martirosyan; Onyebuchi A Arah; Flora M Haaijer-Ruskamp; Jozé Braspenning; Petra Denig
Journal:  BMC Health Serv Res       Date:  2010-05-26       Impact factor: 2.655

10.  How to limit the burden of data collection for Quality Indicators based on medical records? The COMPAQH experience.

Authors:  Clément Corriol; Valentin Daucourt; Catherine Grenier; Etienne Minvielle
Journal:  BMC Health Serv Res       Date:  2008-10-21       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.